Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Chemistry|August 10, 2011
Identification and characterization of a novel integrin-linked kinase inhibitorSu-Lin Lee, En-Chi Hsu, Chih-Chien Chou, et al.International Journal of Radiation Oncology, Biology, Physics|March 3, 2012
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinomaYen-Shen Lu, Chia-Hung Chou, Kai-Yuan Tzen, et al.Journal of Biomedical Science|December 17, 2009
Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agentHao-Chieh Chiu, Shilpa Soni, Samuel K Kulp, et al.Cancer Research|May 17, 2008
OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate modelAaron M Sargeant, Robert C Rengel, Samuel K Kulp, et al.Cancer Research|March 1, 2005
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgammaChung-Wai Shiau, Chih-Cheng Yang, Samuel K Kulp, et al.Journal of Medicinal Chemistry|February 23, 2010
Development of novel adenosine monophosphate-activated protein kinase activatorsJih-Hwa Guh, Wei-Ling Chang, Jian Yang, et al.Toxicologic Pathology|October 25, 2011
A review of the existing grading schemes and a proposal for a modified grading scheme for prostatic lesions in TRAMP miceLisa D Berman-Booty, Aaron M Sargeant, Thomas J Rosol, et al.Cancer Research|July 5, 2014
AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axisChih-Chien Chou, Kuen-Haur Lee, I-Lu Lai, et al.The Journal of Biological Chemistry|July 25, 2008
A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cellsShuo Wei, Hsiao-Ching Yang, Hsiao-Ching Chuang, et al.The Journal of Biological Chemistry|September 16, 2011
Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activatorKuen-Haur Lee, En-Chi Hsu, Jih-Hwa Guh, et al.Pageof 11